Jiang T; Shi W; Wali VB; Pongor, Lőrinc; Li C; Lau R; Győrffy, Balázs; Lifton RP; Symmans WF; Pusztai L; Hatzis C
(2016)
Background: Triple negative breast cancer (TNBC) is a highly heterogeneous and aggressive disease, and although no effective targeted therapies are available to date, about one-third of patients with TNBC achieve pathologic ...